|
시장보고서
상품코드
2079935
아디포넥틴 검사 시장 규모, 점유율, 성장 분석 : 검사 유형별, 용도별, 최종사용자별, 유통 경로별, 지역별 - 업계 예측(2026-2033년)Adiponectin Testing Market Size, Share, and Growth Analysis, By Test Type (ELISA-Based Adiponectin Test, Multiplex Immunoassay), By Application, By End-User, By Distribution, By Region - Industry Forecast 2026-2033 |
||||||
세계의 아디포넥틴 검사 시장 규모는 2024년에 2억 8,250만 달러로 평가되었으며, 2025년 3억 7만 달러에서 2033년까지 4억 8,540만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 6.22%로 성장할 것으로 전망됩니다.
세계 아디포넥틴 검사 시장은 심혈관 위험 알고리즘에 아디포넥틴 측정이 포함됨에 따라 임상의들이 지질 패널과 함께 환자의 계층화를 강화할 수 있게 되었기 때문에 눈부신 성장을 이루고 있습니다. 이러한 시너지 효과로 인해 검사 기관들은 아디포넥틴을 hs-CRP나 나트륨 이뇨 펩타이드 등의 바이오마커와 동시에 측정하는 혁신적인 플랫폼의 도입을 촉진하고 있으며, 이를 통해 워크플로우의 효율화와 비용 절감을 도모하고 있습니다. 각 제약사는 GLP-1 작용제의 임상시험에서 아디포넥틴 바이오마커를 활용하고 있으며, 이는 검사법 채택을 촉진하는 선순환을 만들어내고 있습니다. POC(Point-of-Care)(POC) 기기의 부상은, 특히 대사성 질환 유병률이 높아지고 있는 아시아태평양에서 환자 치료 및 보험 청구 절차를 가속화하고 있습니다. 동시에, 인공지능(AI)의 발전은 검사법 설계와 워크플로우 자동화에 혁명을 일으켜 진단 정확도와 업무 효율을 향상시키고 있으며, 궁극적으로 시장의 지속적인 성장과 접근성 향상을 실현할 기반을 마련하고 있습니다.
세계 아디포넥틴 검사 시장의 성장요인
대사 및 심혈관 건강에 있어 중요한 지표인 아디포넥틴의 중요성에 대한 인식이 소비자 및 의료 종사자들 사이에서 높아지고 있는 것이, 정기 검진에 대한 수요 증가를 뒷받침하고 있습니다. 이러한 이해를 바탕으로 임상의들은 예방 의료 대책에 아디포넥틴 검사를 도입하게 되었으며, 그 결과 진단 검사 기관의 고객층이 확대되고 있습니다. 또한, 아디포넥틴 농도의 중요성을 강조하는 지속적인 계몽 활동과 과학 문헌을 통해 조기 발견이 더욱 활성화되고 있으며, 시장에서의 폭넓은 수용이 촉진되고 있습니다. 그 결과, 진료소에서는 아디포넥틴 검사를 서비스 제공의 우선 과제로 삼아 서비스의 질을 높이는 동시에, 장기적으로 건강 의식이 높은 환자층을 유치하기 위해 노력하고 있습니다.
세계 아디포넥틴 검사 시장의 제약요인
세계 아디포넥틴 검사 시장은 표준 보험 적용 범위에서 아디포넥틴 검사가 빈번히 제외되는 보험 지급 정책으로 인해 환자와 의료 서비스 제공자 모두에게 경제적 장벽이 발생하고 있어 큰 과제에 직면해 있습니다. 그 결과, 의료 종사자들은 이 검사를 처방하는 데 소극적인 경향이 있으며, 이것이 표준적인 1차 진료에 이 검사가 도입되는 것을 방해하고 있습니다. 이러한 소극적인 태도는 특히 비용에 민감한 의료 환경에서 아디포넥틴 검사의 도입에 영향을 미치고 있으며, 임상적 관심은 높음에도 불구하고 잠재적인 시장 성장을 저해하고 있습니다. 게다가 재정 지원 부족으로 인해 검사 기관들이 필요한 전문 장비에 대한 투자를 주저할 가능성이 있으며, 이로 인해 시장 발전이 더욱 저해되면서 정책 변경을 요구하는 목소리가 높아지고 있지만, 이를 실현하는 데는 시간이 걸리고 있습니다.
세계 아디포넥틴 검사 시장의 동향
세계 아디포넥틴 검사 시장에서는 정밀 의학(Precision Medicine)의 통합을 향한 뚜렷한 추세가 나타나고 있으며, 이는 아디포넥틴 검사 수요에 큰 영향을 미치고 있습니다. 의료 종사자들이 대사 위험 프로파일을 바탕으로 환자를 계층화하는 데 있어 바이오마커의 가치를 점점 더 인식함에 따라, 당뇨병, 심혈관질환, 비만 등의 질환에 대한 맞춤형 치료 전략에 대한 중요성이 커지고 있습니다. 이러한 변화에 따라 검사 기관들은 아디포넥틴을 검사 항목에 포함시키기 위해 검사 역량을 확대하고 있으며, 맞춤형 의료 체계 내에서 아디포넥틴의 역할이 확고해지고 있습니다. 또한, 동반진단제 개발을 위한 진단제 제조사와 제약사 간의 제휴도 확대되면서, 세계 시장의 성장과 보급을 더욱 뒷받침하고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 아디포넥틴 검사 시장 규모 : 검사 유형별
세계의 아디포넥틴 검사 시장 규모 : 용도별
세계의 아디포넥틴 검사 시장 규모 : 최종사용자별
세계의 아디포넥틴 검사 시장 규모 : 유통 경로별
세계의 아디포넥틴 검사 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.07.13Global Adiponectin Testing Market size was valued at USD 282.5 Million in 2024 and is poised to grow from USD 300.07 Million in 2025 to USD 485.4 Million by 2033, growing at a CAGR of 6.22% during the forecast period (2026-2033).
The global adiponectin testing market is witnessing significant growth due to the integration of adiponectin measurement into cardiovascular risk algorithms, allowing clinicians to enhance patient stratification alongside lipid panels. This synergy motivates laboratories to adopt innovative platforms that concurrently assess adiponectin with biomarkers such as hs-CRP and natriuretic peptides, thereby streamlining workflows and reducing costs. Pharmaceutical companies leverage adiponectin biomarkers in GLP-1 agonist trials, creating a feedback loop that promotes assay adoption. The rise of point-of-care devices accelerates patient care and reimbursement processes, particularly in the Asia-Pacific region where metabolic diseases are becoming more prevalent. Concurrently, advancements in artificial intelligence are revolutionizing assay design and workflow automation, improving diagnostic accuracy and operational efficiency, ultimately positioning the market for continued growth and accessibility.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Adiponectin Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Adiponectin Testing Market Segments Analysis
Global adiponectin testing market is segmented by test type, application, end-user, distribution and region. Based on test type, the market is segmented into ELISA-Based Adiponectin Test, Multiplex Immunoassay and Radioimmunoassay (RIA). Based on application, the market is segmented into Diabetes & Metabolic Syndrome Research, Cardiovascular Risk Assessment and Obesity Research. Based on end-user, the market is segmented into Research Institutes, Clinical Diagnostic Labs and Pharma & Biotech Companies. Based on distribution, the market is segmented into Direct, Distributors and Online. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Adiponectin Testing Market
The growing awareness among consumers and healthcare professionals about the significance of adiponectin as a vital marker for metabolic and cardiovascular health is fueling increased demand for regular testing. This understanding encourages clinicians to integrate adiponectin testing into preventive healthcare measures, which in turn expands the clientele for diagnostic laboratories. Additionally, ongoing educational initiatives and scientific literature highlighting the importance of adiponectin levels further promote early detection practices, facilitating wider acceptance of the market. As a result, clinics are prioritizing adiponectin assays in their offerings, enhancing their services and appealing to health-conscious patients over the long term.
Restraints in the Global Adiponectin Testing Market
The Global Adiponectin Testing market faces significant challenges due to reimbursement policies that frequently omit adiponectin testing from standard insurance coverage, creating financial obstacles for both patients and healthcare providers. As a result, healthcare professionals may be reluctant to prescribe this test, which hampers its integration into standard primary care practices. This hesitance particularly affects the adoption of adiponectin testing in cost-sensitive healthcare environments, stifling potential market growth despite notable clinical interest. Additionally, the lack of financial support may discourage laboratories from investing in the necessary specialized equipment, further impeding market development and prompting calls for policy changes that are slow to materialize.
Market Trends of the Global Adiponectin Testing Market
The Global Adiponectin Testing market is experiencing a notable trend towards the integration of precision medicine, significantly influencing the demand for adiponectin assays. As healthcare professionals increasingly recognize the value of biomarkers in stratifying patients according to metabolic risk profiles, the emphasis on personalized treatment strategies for conditions such as diabetes, cardiovascular disease, and obesity is intensifying. This shift is prompting laboratories to broaden their testing capabilities to incorporate adiponectin, solidifying its role within personalized care frameworks. Additionally, collaborations between diagnostic companies and pharmaceutical firms to develop companion diagnostics are emerging, further enhancing the market's growth and adoption worldwide.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Adiponectin Testing Market Size by Test Type & CAGR (2026-2033)
- Market Overview
- ELISA-Based Adiponectin Test
- Multiplex Immunoassay
- Radioimmunoassay (RIA)
Global Adiponectin Testing Market Size by Application & CAGR (2026-2033)
- Market Overview
- Diabetes & Metabolic Syndrome Research
- Cardiovascular Risk Assessment
- Obesity Research
Global Adiponectin Testing Market Size by End-User & CAGR (2026-2033)
- Market Overview
- Research Institutes
- Clinical Diagnostic Labs
- Pharma & Biotech Companies
Global Adiponectin Testing Market Size by Distribution & CAGR (2026-2033)
- Market Overview
- Direct
- Distributors
- Online
Global Adiponectin Testing Market Size & CAGR (2026-2033)
- North America (Test Type, Application, End-User, Distribution)
- US
- Canada
- Europe (Test Type, Application, End-User, Distribution)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Test Type, Application, End-User, Distribution)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Test Type, Application, End-User, Distribution)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Test Type, Application, End-User, Distribution)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- R&D Systems (Bio-Techne)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Sigma-Aldrich)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioVendor Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Adipogen Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Invitrogen (Thermo Fisher)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meso Scale Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alpco Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mediagnost GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Adipo Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RayBiotech Life
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Assaypro LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aviva Systems Biology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elabscience Biotechnology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cloud-Clone Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boster Biological Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EagleBiosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AssayPro
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
